SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-014863
Filing Date
2020-08-06
Accepted
2020-08-06 16:22:45
Documents
53
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1320541
2 ex31-1.htm EX-31.1 17735
3 ex31-2.htm EX-31.2 17640
4 ex32-1.htm EX-32.1 6583
5 ex32-2.htm EX-32.2 6728
  Complete submission text file 0001493152-20-014863.txt   5825562

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE orgs-20200630.xsd EX-101.SCH 45036
7 XBRL CALCULATION FILE orgs-20200630_cal.xml EX-101.CAL 59243
8 XBRL DEFINITION FILE orgs-20200630_def.xml EX-101.DEF 142687
9 XBRL LABEL FILE orgs-20200630_lab.xml EX-101.LAB 396186
10 XBRL PRESENTATION FILE orgs-20200630_pre.xml EX-101.PRE 280987
11 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 939605
Mailing Address 20271 GOLDENROD LANE GERMANTOWN MD 20876
Business Address 20271 GOLDENROD LANE GERMANTOWN MD 20876 (480) 659-6404
Orgenesis Inc. (Filer) CIK: 0001460602 (see all company filings)

IRS No.: 980583166 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38416 | Film No.: 201082045
SIC: 2834 Pharmaceutical Preparations